CURRENT UPDATES ON ANTI-DIABETIC THERAPY
Diabetes globally has become one of the chronic public health problems and is related to group of metabolic defects resulting due to defect in insulin secretion and its action. As the disease progress micro and macro vascular damage may lead to retinopathy, neuropathy, nephropathy and various cardiovascular like complications. It is estimated that by the year of 2030 about 439 million adults would be suffering from any form of diabetes. There are mainly two types of diabetes which is because of their occurrence rate. The current review covers the basic aspect of types of diabetes, insulin molecular, chemical basis, and its secretion, hypoglycemic drugs used and their mode of action, what are the recent advancement in terms of new drugs finding, and the herbal plants. Thus, the information will help researchers for development of combination medication which involve both recent medication and herbal medication for combating various complication associated with diabetes.
KEY WORDS: Hyperglycemia, insulin, glucose, phyto-constituents.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).